Imlunestrant: First Approval
Susan J. Keam
Topics & Concepts
MedicineMetastatic breast cancerBreast cancerOncologyInternal medicineEndocrine systemEstrogen receptorDrug developmentDrug approvalDiseasePharmacotherapyGynecologyCancerHuman Epidermal Growth Factor Receptor 2Targeted therapyIntensive care medicineClinical pharmacologyEstrogenFulvestrantEpidermal growth factor receptorBreast diseaseClinical OncologySystemic therapyFood and drug administrationAromataseFirst line treatmentEstrogen and related hormone effectsAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer Research